...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Phlebology >Ultrasound-guided foam sclerotherapy within a rolling treatment programme is an effective low-cost treatment for superficial venous insufficiency.
【24h】

Ultrasound-guided foam sclerotherapy within a rolling treatment programme is an effective low-cost treatment for superficial venous insufficiency.

机译：滚动治疗程序中的超声引导泡沫硬化疗法是治疗浅表静脉功能不全的一种有效的低成本治疗方法。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

To review the results and cost of a rolling ultrasound-guided foam sclerotherapy (UGFS) treatment programme for patients with chronic superficial venous insufficiency.A prospective study of a rolling treatment programme where patients were offered unlimited follow-up at intervals of 6-8 weeks and further (top up) UGFS when necessary, until occlusion criteria were met.A total of 213 lower limbs with complete follow-up were included in the study. Median (range) age was 57 (16-94) years, maximum diameter of varicose vein was 10 (3-18) mm, C of CEAP (clinical, aetiological, anatomical and pathological elements) was 4 (2-6), number of treatment sessions was one (1-4) and follow-up was three (1.5-33) months. Satisfactory occlusion could not be achieved in nine (4%) limbs. The ratio of odds (95% CI) for requiring more than one treatment session was 3.58 (1.46-8.77), P = 0.002 for great saphenous varicosity and 2.11 (1.13-3.94), P = 0.015 for age 50 or more. There were 20 (9.3%) immediate and 63 (29.5%) delayed adverse effects. All were minor except for one cutaneous nerve injury, one pulmonary embolism and one infected haematoma. The ratio for odds (95% CI) for post-treatment skin discolouration was 2.59 (1.14-5.87), P = 0.017 for women and 1.32 (1.02-1.71), P = 0.032 for increasing sclerosant volume used. Service line costing per completed treatment episode was ￡115.22 (?130.07, $188.60).UGFS in a rolling treatment programme is safe and can achieve high occlusion rates at a low cost. Patients above the age of 50 with great saphenous varicosity are likely to require more than one treatment session.
机译：回顾针对慢性浅表静脉功能不全的滚动超声引导泡沫硬化疗法（UGFS）治疗方案的结果和成本。一项对滚动治疗方案的前瞻性研究，其中对患者进行6-8周的无限制随访并在必要时进一步进行（补足）UGFS，直至达到阻塞标准。该研究共包括213个下肢，并进行了完整的随访。中位年龄范围为57（16-94）岁，最大静脉曲张直径为10（3-18）mm，CEAP的C（临床，病因，解剖学和病理学因素）值为4（2-6），数量治疗时间为一（1-4）个月，随访为三（1.5-33）个月。 9个（4％）肢体无法获得令人满意的闭塞。需要进行一次以上治疗的几率（95％CI）为3.58（1.46-8.77），大隐静脉曲张率为P = 0.002，而大隐静脉曲张为2.11（1.13-3.94），对于50岁以上的人为P = 0.015。有20（9.3％）的即时不良反应和63（29.5％）的延迟不良反应。除1例皮肤神经损伤，1例肺栓塞和1例感染性血肿外，其余均为轻度。治疗后皮肤变色的几率（95％CI）为2.59（1.14-5.87），女性为P = 0.017，而使用增加的硬化剂体积则为1.32（1.02-1.71），P = 0.032。每完成一次治疗的服务费用为115.22英镑（130.07欧元，188.60美元）。滚动治疗程序中的UGFS是安全的，可以低成本实现高阻塞率。 50岁以上具有大隐静脉曲张的患者可能需要不止一次治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号